Methylenedioxymethamphetamine (MDMA) in Psychiatry

Overview of attention for article published in Journal of Clinical Psychopharmacology, December 2018

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (78th percentile)
High Attention Score compared to outputs of the same age and source (91st percentile)

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 5,551 followers.

RT @JCPjrnl_online: Current Issue: Methylenedioxymethamphetamine (MDMA) in Psychiatry: Pros, Cons, and Suggestions https://t.co/JRLTl1yktS

Current Issue: Methylenedioxymethamphetamine (MDMA) in Psychiatry: Pros, Cons, and Suggestions https://t.co/JRLTl1yktS

Methylenedioxymethamphetamine (MDMA) in Psychiatry: Pros, Cons, and Suggestions. https://t.co/uixTjcFLZS

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.